Advances and Challenges in the Multidisciplinary Treatment of Retroperitoneal Infantile Fibrosarcoma in Early Life
European Journal of Haematology · 2026-09 · 117 (3) · 548-555
DOI: 10.1111/ejh.70163 ↗Kurz gefasst
Fallbericht in der Zeitschrift European Journal of Haematology, online erschienen am 18.03.2026. Verfasst von Gaia Brunetti und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Tor Vergata, Rome, Italy. Hauptthemen laut MEDLINE: Fibrosarcoma, Retroperitoneal Neoplasms. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Background and Aims Retroperitoneal Infantile Fibrosarcoma (RIFS) is a rare, locally aggressive pediatric soft tissue tumor. Its retroperitoneal location poses challenges due to proximity and potential invasion of critical structures such as the inferior vena cava (IVC). This study aims to illustrate the range of multidisciplinary management strategies and evolving therapeutic approaches.
Methods
We conducted a retrospective case series of infants diagnosed with RIFS and treated at our tertiary center. Clinical presentation, imaging findings, histopathology, treatment modalities (including chemotherapy, surgery, interventional radiology, targeted therapies), and follow‐up data were analyzed.
Results
Three infants with histologically confirmed RIFS were identified, with a median age at diagnosis of 2 months (range: 0–8 months). Diagnosis was established through open surgical biopsy. Management was individualized and multimodal, including neoadjuvant chemotherapy, surgical resection, interventional radiology procedures for symptom control, and, in the most recent case, targeted molecular therapy guided by genetic profiling.
Conclusions
Management of RIFS has significantly evolved over the last decade. Advances in surgical techniques combined with the integration of interventional radiology and novel targeted therapies allow a nuanced balance between maximizing oncological control and minimizing surgical morbidity. Multidisciplinary individualized treatment is essential to optimize outcomes in this rare and challenging pediatric tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Tor Vergata, Rome, Italy.
- Academy of Surgery, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Surgical Oncology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Onco-Hematology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Diagnostic and Interventional Radiology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Pathology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
ORCID-Profile: Angelo Zarfati, Giorgio Persano, Ida Russo, Alessandro Crocoli
Förderung
- Ministero della Salute
Zitieren
APA
Brunetti, G., Zarfati, A., Persano, G., Milano, G. M., Russo, I., Natali, G. L., Alaggio, R., Crocoli, A., & Grimaldi, C. (2026). Advances and Challenges in the Multidisciplinary Treatment of Retroperitoneal Infantile Fibrosarcoma in Early Life. European Journal of Haematology, 117(3), 548-555. https://doi.org/10.1111/ejh.70163
Vancouver
Brunetti G, Zarfati A, Persano G, Milano GM, Russo I, Natali GL, et al. Advances and Challenges in the Multidisciplinary Treatment of Retroperitoneal Infantile Fibrosarcoma in Early Life. European Journal of Haematology. 2026;117(3):548-555. doi:10.1111/ejh.70163
BibTeX
@article{Brunetti2026,
author = {Brunetti, Gaia and Zarfati, Angelo and Persano, Giorgio and Milano, Giuseppe Maria and Russo, Ida and Natali, Gian Luigi and Alaggio, Rita and Crocoli, Alessandro and Grimaldi, Chiara},
title = {Advances and Challenges in the Multidisciplinary Treatment of Retroperitoneal Infantile Fibrosarcoma in Early Life},
journal = {European Journal of Haematology},
year = {2026},
volume = {117},
number = {3},
pages = {548--555},
doi = {10.1111/ejh.70163}
}
EUVIMED